Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Total Liabilities & Equity Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Liabilities & Equity
$549.4m
CAGR 3-Years
15%
CAGR 5-Years
30%
CAGR 10-Years
26%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Liabilities & Equity
CA$20m
CAGR 3-Years
183%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Liabilities & Equity
$69.7m
CAGR 3-Years
-18%
CAGR 5-Years
-8%
CAGR 10-Years
9%
Repare Therapeutics Inc
NASDAQ:RPTX
Total Liabilities & Equity
$253.9m
CAGR 3-Years
-11%
CAGR 5-Years
79%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Total Liabilities & Equity
CA$26.5m
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
11%
Spectral Medical Inc
TSX:EDT
Total Liabilities & Equity
CA$8.2m
CAGR 3-Years
-16%
CAGR 5-Years
10%
CAGR 10-Years
-5%

See Also

What is Aurinia Pharmaceuticals Inc's Total Liabilities & Equity?
Total Liabilities & Equity
549.4m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Total Liabilities & Equity amounts to 549.4m USD.

What is Aurinia Pharmaceuticals Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
26%

Over the last year, the Total Liabilities & Equity growth was -1%. The average annual Total Liabilities & Equity growth rates for Aurinia Pharmaceuticals Inc have been 15% over the past three years , 30% over the past five years , and 26% over the past ten years .

Back to Top